Skip to main content
. Author manuscript; available in PMC: 2017 Jun 1.
Published in final edited form as: Vet Comp Oncol. 2013 Nov 21;14(2):e4–e16. doi: 10.1111/vco.12077

Figure 2.

Figure 2

Figure 2A–G. Evaluation of siRNA targeting β-catenin behavioral effects. There were no consistent differences between siRNA-treated cells and negative control siRNA-treated cells for (A) proliferation at 24 hours, (B) proliferation over a 72-hour time course, (C) apoptosis, (D) doxorubicin sensitivity, (E) invasion, or (F) migration. There was also no change in β-catenin transcriptional activity as measured by TCF-responsive luciferase reporter assay (G). All calculations are a 2-way ANOVA with Sidak’s post-test.